Neovasc (NASDAQ:NVCN – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.
Valuation and Earnings
This table compares Neovasc and INVO Bioscience’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Neovasc||$2.55 million||10.20||-$24.89 million||($0.37)||-1.04|
|INVO Bioscience||$4.16 million||5.46||-$6.66 million||($1.26)||-1.49|
This is a summary of recent ratings and recommmendations for Neovasc and INVO Bioscience, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Neovasc presently has a consensus price target of $5.00, indicating a potential upside of 1,200.73%. INVO Bioscience has a consensus price target of $4.50, indicating a potential upside of 139.36%. Given Neovasc’s stronger consensus rating and higher possible upside, analysts clearly believe Neovasc is more favorable than INVO Bioscience.
Volatility & Risk
Neovasc has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500. Comparatively, INVO Bioscience has a beta of -0.79, suggesting that its share price is 179% less volatile than the S&P 500.
Institutional & Insider Ownership
2.1% of Neovasc shares are held by institutional investors. Comparatively, 14.8% of INVO Bioscience shares are held by institutional investors. 7.6% of INVO Bioscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This table compares Neovasc and INVO Bioscience’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Neovasc beats INVO Bioscience on 8 of the 14 factors compared between the two stocks.
Neovasc Company Profile (Get Rating)
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.
INVO Bioscience Company Profile (Get Rating)
INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.